Our observation, APS did not affect IL-1β-mediated phosphorylation of p38 MAP kinase, may explain why this agent—despite of its effect on NF-κB gene expression—failed to reduce IL-1β-mediated secretion of IL-6 and IL-8. This evidence concerns the gene NFKB1 and autoimmune polyendocrinopathy.